Pharma & Healthcare

Prescription Migraine Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Prescription migraine medicines are medications that require a doctor's prescription and are specifically designed to treat migraines. These medications are typically more potent and targeted in their approach to managing migraine symptoms.
The global market for Prescription Migraine Medicine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Headaches and migraines are common conditions affecting a significant portion of the population. The increasing prevalence of these conditions drives the demand for prescription headache medicines as individuals seek effective treatment options to manage their symptoms. While over-the-counter medications can provide relief for many individuals with mild headaches, there is a substantial population that experiences moderate to severe headaches or migraines that require stronger prescription medications. The unmet medical needs of this population drive the demand for prescription headache medicines.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prescription Migraine Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Prescription Migraine Medicine by region & country, by Type, and by Application.
The Prescription Migraine Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Migraine Medicine.
Market Segmentation
By Company
GSK
Teva
Pfizer
Amgen
Viatris
Allergan
Grunenthal
Eli Lilly
Segment by Type:
Sumatriptan
Rizatriptan
Others
Segment by Application
Hospital
Clinic
Drug Store
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Prescription Migraine Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Prescription Migraine Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Prescription Migraine Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Prescription Migraine Medicine Product Introduction
1.2 Global Prescription Migraine Medicine Market Size Forecast
1.3 Prescription Migraine Medicine Market Trends & Drivers
1.3.1 Prescription Migraine Medicine Industry Trends
1.3.2 Prescription Migraine Medicine Market Drivers & Opportunity
1.3.3 Prescription Migraine Medicine Market Challenges
1.3.4 Prescription Migraine Medicine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Prescription Migraine Medicine Players Revenue Ranking (2023)
2.2 Global Prescription Migraine Medicine Revenue by Company (2019-2024)
2.3 Key Companies Prescription Migraine Medicine Manufacturing Base Distribution and Headquarters
2.4 Key Companies Prescription Migraine Medicine Product Offered
2.5 Key Companies Time to Begin Mass Production of Prescription Migraine Medicine
2.6 Prescription Migraine Medicine Market Competitive Analysis
2.6.1 Prescription Migraine Medicine Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Prescription Migraine Medicine Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Migraine Medicine as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sumatriptan
3.1.2 Rizatriptan
3.1.3 Others
3.2 Global Prescription Migraine Medicine Sales Value by Type
3.2.1 Global Prescription Migraine Medicine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Prescription Migraine Medicine Sales Value, by Type (2019-2030)
3.2.3 Global Prescription Migraine Medicine Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Drug Store
4.2 Global Prescription Migraine Medicine Sales Value by Application
4.2.1 Global Prescription Migraine Medicine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Prescription Migraine Medicine Sales Value, by Application (2019-2030)
4.2.3 Global Prescription Migraine Medicine Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Prescription Migraine Medicine Sales Value by Region
5.1.1 Global Prescription Migraine Medicine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Prescription Migraine Medicine Sales Value by Region (2019-2024)
5.1.3 Global Prescription Migraine Medicine Sales Value by Region (2025-2030)
5.1.4 Global Prescription Migraine Medicine Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Prescription Migraine Medicine Sales Value, 2019-2030
5.2.2 North America Prescription Migraine Medicine Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Prescription Migraine Medicine Sales Value, 2019-2030
5.3.2 Europe Prescription Migraine Medicine Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Prescription Migraine Medicine Sales Value, 2019-2030
5.4.2 Asia Pacific Prescription Migraine Medicine Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Prescription Migraine Medicine Sales Value, 2019-2030
5.5.2 South America Prescription Migraine Medicine Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Prescription Migraine Medicine Sales Value, 2019-2030
5.6.2 Middle East & Africa Prescription Migraine Medicine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Prescription Migraine Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Prescription Migraine Medicine Sales Value
6.3 United States
6.3.1 United States Prescription Migraine Medicine Sales Value, 2019-2030
6.3.2 United States Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Prescription Migraine Medicine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Prescription Migraine Medicine Sales Value, 2019-2030
6.4.2 Europe Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Prescription Migraine Medicine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Prescription Migraine Medicine Sales Value, 2019-2030
6.5.2 China Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Prescription Migraine Medicine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Prescription Migraine Medicine Sales Value, 2019-2030
6.6.2 Japan Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Prescription Migraine Medicine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Prescription Migraine Medicine Sales Value, 2019-2030
6.7.2 South Korea Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Prescription Migraine Medicine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Prescription Migraine Medicine Sales Value, 2019-2030
6.8.2 Southeast Asia Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Prescription Migraine Medicine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Prescription Migraine Medicine Sales Value, 2019-2030
6.9.2 India Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Prescription Migraine Medicine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GSK
7.1.1 GSK Profile
7.1.2 GSK Main Business
7.1.3 GSK Prescription Migraine Medicine Products, Services and Solutions
7.1.4 GSK Prescription Migraine Medicine Revenue (US$ Million) & (2019-2024)
7.1.5 GSK Recent Developments
7.2 Teva
7.2.1 Teva Profile
7.2.2 Teva Main Business
7.2.3 Teva Prescription Migraine Medicine Products, Services and Solutions
7.2.4 Teva Prescription Migraine Medicine Revenue (US$ Million) & (2019-2024)
7.2.5 Teva Recent Developments
7.3 Pfizer
7.3.1 Pfizer Profile
7.3.2 Pfizer Main Business
7.3.3 Pfizer Prescription Migraine Medicine Products, Services and Solutions
7.3.4 Pfizer Prescription Migraine Medicine Revenue (US$ Million) & (2019-2024)
7.3.5 Amgen Recent Developments
7.4 Amgen
7.4.1 Amgen Profile
7.4.2 Amgen Main Business
7.4.3 Amgen Prescription Migraine Medicine Products, Services and Solutions
7.4.4 Amgen Prescription Migraine Medicine Revenue (US$ Million) & (2019-2024)
7.4.5 Amgen Recent Developments
7.5 Viatris
7.5.1 Viatris Profile
7.5.2 Viatris Main Business
7.5.3 Viatris Prescription Migraine Medicine Products, Services and Solutions
7.5.4 Viatris Prescription Migraine Medicine Revenue (US$ Million) & (2019-2024)
7.5.5 Viatris Recent Developments
7.6 Allergan
7.6.1 Allergan Profile
7.6.2 Allergan Main Business
7.6.3 Allergan Prescription Migraine Medicine Products, Services and Solutions
7.6.4 Allergan Prescription Migraine Medicine Revenue (US$ Million) & (2019-2024)
7.6.5 Allergan Recent Developments
7.7 Grunenthal
7.7.1 Grunenthal Profile
7.7.2 Grunenthal Main Business
7.7.3 Grunenthal Prescription Migraine Medicine Products, Services and Solutions
7.7.4 Grunenthal Prescription Migraine Medicine Revenue (US$ Million) & (2019-2024)
7.7.5 Grunenthal Recent Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Profile
7.8.2 Eli Lilly Main Business
7.8.3 Eli Lilly Prescription Migraine Medicine Products, Services and Solutions
7.8.4 Eli Lilly Prescription Migraine Medicine Revenue (US$ Million) & (2019-2024)
7.8.5 Eli Lilly Recent Developments
8 Industry Chain Analysis
8.1 Prescription Migraine Medicine Industrial Chain
8.2 Prescription Migraine Medicine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Prescription Migraine Medicine Sales Model
8.5.2 Sales Channel
8.5.3 Prescription Migraine Medicine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Prescription Migraine Medicine Market Trends
Table 2. Prescription Migraine Medicine Market Drivers & Opportunity
Table 3. Prescription Migraine Medicine Market Challenges
Table 4. Prescription Migraine Medicine Market Restraints
Table 5. Global Prescription Migraine Medicine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Prescription Migraine Medicine Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Prescription Migraine Medicine Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Prescription Migraine Medicine Product Type
Table 9. Key Companies Time to Begin Mass Production of Prescription Migraine Medicine
Table 10. Global Prescription Migraine Medicine Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Migraine Medicine as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Prescription Migraine Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Prescription Migraine Medicine Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Prescription Migraine Medicine Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Prescription Migraine Medicine Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Prescription Migraine Medicine Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Prescription Migraine Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Prescription Migraine Medicine Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Prescription Migraine Medicine Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Prescription Migraine Medicine Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Prescription Migraine Medicine Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Prescription Migraine Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Prescription Migraine Medicine Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Prescription Migraine Medicine Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Prescription Migraine Medicine Sales Value by Region (2019-2024) & (%)
Table 27. Global Prescription Migraine Medicine Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Prescription Migraine Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Prescription Migraine Medicine Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Prescription Migraine Medicine Sales Value, (2025-2030) & (US$ Million)
Table 31. GSK Basic Information List
Table 32. GSK Description and Business Overview
Table 33. GSK Prescription Migraine Medicine Products, Services and Solutions
Table 34. Revenue (US$ Million) in Prescription Migraine Medicine Business of GSK (2019-2024)
Table 35. GSK Recent Developments
Table 36. Teva Basic Information List
Table 37. Teva Description and Business Overview
Table 38. Teva Prescription Migraine Medicine Products, Services and Solutions
Table 39. Revenue (US$ Million) in Prescription Migraine Medicine Business of Teva (2019-2024)
Table 40. Teva Recent Developments
Table 41. Pfizer Basic Information List
Table 42. Pfizer Description and Business Overview
Table 43. Pfizer Prescription Migraine Medicine Products, Services and Solutions
Table 44. Revenue (US$ Million) in Prescription Migraine Medicine Business of Pfizer (2019-2024)
Table 45. Pfizer Recent Developments
Table 46. Amgen Basic Information List
Table 47. Amgen Description and Business Overview
Table 48. Amgen Prescription Migraine Medicine Products, Services and Solutions
Table 49. Revenue (US$ Million) in Prescription Migraine Medicine Business of Amgen (2019-2024)
Table 50. Amgen Recent Developments
Table 51. Viatris Basic Information List
Table 52. Viatris Description and Business Overview
Table 53. Viatris Prescription Migraine Medicine Products, Services and Solutions
Table 54. Revenue (US$ Million) in Prescription Migraine Medicine Business of Viatris (2019-2024)
Table 55. Viatris Recent Developments
Table 56. Allergan Basic Information List
Table 57. Allergan Description and Business Overview
Table 58. Allergan Prescription Migraine Medicine Products, Services and Solutions
Table 59. Revenue (US$ Million) in Prescription Migraine Medicine Business of Allergan (2019-2024)
Table 60. Allergan Recent Developments
Table 61. Grunenthal Basic Information List
Table 62. Grunenthal Description and Business Overview
Table 63. Grunenthal Prescription Migraine Medicine Products, Services and Solutions
Table 64. Revenue (US$ Million) in Prescription Migraine Medicine Business of Grunenthal (2019-2024)
Table 65. Grunenthal Recent Developments
Table 66. Eli Lilly Basic Information List
Table 67. Eli Lilly Description and Business Overview
Table 68. Eli Lilly Prescription Migraine Medicine Products, Services and Solutions
Table 69. Revenue (US$ Million) in Prescription Migraine Medicine Business of Eli Lilly (2019-2024)
Table 70. Eli Lilly Recent Developments
Table 71. Key Raw Materials Lists
Table 72. Raw Materials Key Suppliers Lists
Table 73. Prescription Migraine Medicine Downstream Customers
Table 74. Prescription Migraine Medicine Distributors List
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Prescription Migraine Medicine Product Picture
Figure 2. Global Prescription Migraine Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Prescription Migraine Medicine Sales Value (2019-2030) & (US$ Million)
Figure 4. Prescription Migraine Medicine Report Years Considered
Figure 5. Global Prescription Migraine Medicine Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Prescription Migraine Medicine Revenue in 2023
Figure 7. Prescription Migraine Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Sumatriptan Picture
Figure 9. Rizatriptan Picture
Figure 10. Others Picture
Figure 11. Global Prescription Migraine Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Prescription Migraine Medicine Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospital
Figure 14. Product Picture of Clinic
Figure 15. Product Picture of Drug Store
Figure 16. Global Prescription Migraine Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Prescription Migraine Medicine Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Prescription Migraine Medicine Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Prescription Migraine Medicine Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Prescription Migraine Medicine Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Prescription Migraine Medicine Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Prescription Migraine Medicine Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Prescription Migraine Medicine Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Prescription Migraine Medicine Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Prescription Migraine Medicine Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Prescription Migraine Medicine Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Prescription Migraine Medicine Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Prescription Migraine Medicine Sales Value (%), (2019-2030)
Figure 29. United States Prescription Migraine Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Prescription Migraine Medicine Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Prescription Migraine Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Prescription Migraine Medicine Sales Value by Application (%), 2023 VS 2030
Figure 35. China Prescription Migraine Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
Figure 37. China Prescription Migraine Medicine Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Prescription Migraine Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Prescription Migraine Medicine Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Prescription Migraine Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Prescription Migraine Medicine Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Prescription Migraine Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Prescription Migraine Medicine Sales Value by Application (%), 2023 VS 2030
Figure 47. India Prescription Migraine Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Prescription Migraine Medicine Sales Value by Type (%), 2023 VS 2030
Figure 49. India Prescription Migraine Medicine Sales Value by Application (%), 2023 VS 2030
Figure 50. Prescription Migraine Medicine Industrial Chain
Figure 51. Prescription Migraine Medicine Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies